VMD: Explanation for consolidated business result in QII/2012

Vimedimex Medi – Pharma Joint Stock Company explained the fluctuation in consolidated profit in Quarter II/2012 compared to Quarter II/2011 as follows:

-         Net revenue increased 25.65% (VND448.02 billion) and cost of goods sold increased 27.92% (VND438.35 billion).

-         Gross profit increased 5.89% (VND10.67 billion) but total cost  increased 9.14% (VND15.72 billion) leading to net profit decreased 227.44% (VND5.05 billion) because of company restructuring.

-         Therefore, profit before tax in Quarter 2/2012 decreased 177.30% (VND10.67 billion) compared to in Quarter 2/2011 and profit after tax in Quarter 2/2012 decreased 205.43% (VND3.9 billion) compared to in Quarter 2/2011

HOSE

>   VSI: Change of Business registration certificate (28/09/2012)

>   DLG: Explanation for Single – entity financial statements for 6 months of 2012 after review (28/09/2012)

>   ACBS: Change of Branch Address (28/09/2012)

>   PSI: PSI closes a branch (28/09/2012)

>   VCH: Notice of record date for Annual General Meeting of Shareholders (28/09/2012)

>   AGRISECO: AGRISECO adjusts some items in the semi-annual financial statements (27/09/2012)

>   ACB: Reviewed financial statement 2012 (27/09/2012)

>   TMP: Explanation for financial statements for 6 months (27/09/2012)

>   Sacombank-SBS: Consolidated financial statements of Quarter 2.2012 & the semi-annual consolidated financial statements 2012 (27/09/2012)

>   HPG spends $12.7 mln on shares mortgaged at ACB (26/09/2012)